# Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)

> **NCT00756418** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 84 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** montelukast
- **DRUG:** Theophylline

## Key facts

- **NCT ID:** NCT00756418
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06-01
- **Primary completion:** 2004-08-28
- **Final completion:** 2004-08-28
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756418, "Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00756418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*